EP3246328 - QUINAZOLINE HETEROCYCLIC COMPOUND AS EGFR KINASE INHIBITOR, AND PREPARATION AND APPLICATION THEREOF [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 28.05.2021 Database last updated on 31.08.2024 | |
Former | The patent has been granted Status updated on 19.06.2020 | ||
Former | Grant of patent is intended Status updated on 01.01.2020 | ||
Former | Examination is in progress Status updated on 07.12.2018 | ||
Former | Request for examination was made Status updated on 20.10.2017 | ||
Former | The international publication has been made Status updated on 07.07.2017 | Most recent event Tooltip | 27.04.2024 | Lapse of the patent in a contracting state New state(s): MK | published on 29.05.2024 [2024/22] | Applicant(s) | For all designated states Beijing Scitech-MQ Pharmaceuticals Limited No.10 Linhe North Street Shunyi District Beijing 101300 / CN | [2020/30] |
Former [2017/47] | For all designated states Beijing Scitech-MQ Pharmaceuticals Limited No.10 Linhe North Street Shunyi District Beijing 101300 / CN | Inventor(s) | 01 /
SHENG, Wang No.10 Linhe North Street Shunyi District Beijing 101300 / CN | 02 /
YANG, Leifu No.10 Linhe North Street Shunyi District Beijing 101300 / CN | 03 /
PAN, Zhiyong No.10 Linhe North Street Shunyi District Beijing 101300 / CN | [2017/47] | Representative(s) | Kayahan, Senem, et al Yalciner Patent and Consulting Ltd. Tunus Cad. No: 85/3-4 Kavaklidere Cankaya 06680 Ankara / TR | [2020/30] |
Former [2017/47] | Karaahmet, Erdogan Yalciner Patent and Consulting Ltd. Tunus Cad. 85/3-4 Kavaklidere Cankaya 06680 Ankara / TR | Application number, filing date | 16737072.5 | 12.01.2016 | [2017/47] | WO2016CN70736 | Priority number, date | CN20151015411 | 13.01.2015 Original published format: CN201510015411 | [2017/47] | Filing language | ZH | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2016112847 | Date: | 21.07.2016 | Language: | ZH | [2016/29] | Type: | A1 Application with search report | No.: | EP3246328 | Date: | 22.11.2017 | Language: | EN | [2017/47] | Type: | B1 Patent specification | No.: | EP3246328 | Date: | 22.07.2020 | Language: | EN | [2020/30] | Search report(s) | International search report - published on: | CN | 21.07.2016 | (Supplementary) European search report - dispatched on: | EP | 08.05.2018 | Classification | IPC: | C07D491/056, C07D498/04, A61P35/00, A61P35/02, A61K31/5375 | [2018/23] | CPC: |
A61P35/02 (EP,US);
C07D491/056 (EP,CN,US);
C07D239/94 (US);
A61K31/357 (EP,US);
A61K31/517 (EP,US);
A61K31/5375 (EP,US);
A61K39/3955 (US);
C07D405/14 (US);
C07D498/04 (EP,CN,US);
A61K2300/00 (US)
(-)
|
Former IPC [2017/47] | C07D491/056, C07D498/04, A61P35/00, A61P35/02 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2017/47] | Extension states | BA | Not yet paid | ME | Not yet paid | Validation states | MA | Not yet paid | MD | Not yet paid | Title | German: | HETEROCYCLISCHE CHINAZOLINVERBINDUNG ALS EGFR-KINASE-INHIBITOREN SOWIE HERSTELLUNG UND ANWENDUNG DAVON | [2017/47] | English: | QUINAZOLINE HETEROCYCLIC COMPOUND AS EGFR KINASE INHIBITOR, AND PREPARATION AND APPLICATION THEREOF | [2017/47] | French: | COMPOSÉ HÉTÉROCYCLIQUE QUINAZOLÉINE COMME INHIBITEUR DE L'EGFR KINASE, SON PROCÉDÉ DE PRÉPARATION ET SON APPLICATION | [2017/47] | Entry into regional phase | 07.07.2017 | Translation filed | 10.07.2017 | National basic fee paid | 10.07.2017 | Search fee paid | 10.07.2017 | Designation fee(s) paid | 10.07.2017 | Examination fee paid | Examination procedure | 07.07.2017 | Date on which the examining division has become responsible | 10.07.2017 | Examination requested [2017/47] | 25.07.2018 | Amendment by applicant (claims and/or description) | 11.12.2018 | Despatch of a communication from the examining division (Time limit: M04) | 01.04.2019 | Reply to a communication from the examining division | 04.07.2019 | Despatch of a communication from the examining division (Time limit: M02) | 01.08.2019 | Reply to a communication from the examining division | 02.01.2020 | Communication of intention to grant the patent | 10.03.2020 | Fee for grant paid | 10.03.2020 | Fee for publishing/printing paid | 10.03.2020 | Receipt of the translation of the claim(s) | Opposition(s) | 23.04.2021 | No opposition filed within time limit [2021/26] | Fees paid | Renewal fee | 09.11.2017 | Renewal fee patent year 03 | 17.12.2018 | Renewal fee patent year 04 | 10.01.2020 | Renewal fee patent year 05 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | HU | 12.01.2016 | AL | 22.07.2020 | AT | 22.07.2020 | CY | 22.07.2020 | CZ | 22.07.2020 | DK | 22.07.2020 | EE | 22.07.2020 | ES | 22.07.2020 | FI | 22.07.2020 | HR | 22.07.2020 | IT | 22.07.2020 | LT | 22.07.2020 | LV | 22.07.2020 | MC | 22.07.2020 | MK | 22.07.2020 | NL | 22.07.2020 | PL | 22.07.2020 | RO | 22.07.2020 | RS | 22.07.2020 | SE | 22.07.2020 | SI | 22.07.2020 | SK | 22.07.2020 | SM | 22.07.2020 | BG | 22.10.2020 | NO | 22.10.2020 | GR | 23.10.2020 | IS | 22.11.2020 | PT | 23.11.2020 | IE | 12.01.2021 | LU | 12.01.2021 | BE | 31.01.2021 | CH | 31.01.2021 | LI | 31.01.2021 | [2024/22] |
Former [2023/30] | HU | 12.01.2016 | |
AL | 22.07.2020 | ||
AT | 22.07.2020 | ||
CY | 22.07.2020 | ||
CZ | 22.07.2020 | ||
DK | 22.07.2020 | ||
EE | 22.07.2020 | ||
ES | 22.07.2020 | ||
FI | 22.07.2020 | ||
HR | 22.07.2020 | ||
IT | 22.07.2020 | ||
LT | 22.07.2020 | ||
LV | 22.07.2020 | ||
MC | 22.07.2020 | ||
NL | 22.07.2020 | ||
PL | 22.07.2020 | ||
RO | 22.07.2020 | ||
RS | 22.07.2020 | ||
SE | 22.07.2020 | ||
SI | 22.07.2020 | ||
SK | 22.07.2020 | ||
SM | 22.07.2020 | ||
BG | 22.10.2020 | ||
NO | 22.10.2020 | ||
GR | 23.10.2020 | ||
IS | 22.11.2020 | ||
PT | 23.11.2020 | ||
IE | 12.01.2021 | ||
LU | 12.01.2021 | ||
BE | 31.01.2021 | ||
CH | 31.01.2021 | ||
LI | 31.01.2021 | ||
Former [2023/27] | HU | 12.01.2016 | |
AL | 22.07.2020 | ||
AT | 22.07.2020 | ||
CZ | 22.07.2020 | ||
DK | 22.07.2020 | ||
EE | 22.07.2020 | ||
ES | 22.07.2020 | ||
FI | 22.07.2020 | ||
HR | 22.07.2020 | ||
IT | 22.07.2020 | ||
LT | 22.07.2020 | ||
LV | 22.07.2020 | ||
MC | 22.07.2020 | ||
NL | 22.07.2020 | ||
PL | 22.07.2020 | ||
RO | 22.07.2020 | ||
RS | 22.07.2020 | ||
SE | 22.07.2020 | ||
SI | 22.07.2020 | ||
SK | 22.07.2020 | ||
SM | 22.07.2020 | ||
BG | 22.10.2020 | ||
NO | 22.10.2020 | ||
GR | 23.10.2020 | ||
IS | 22.11.2020 | ||
PT | 23.11.2020 | ||
IE | 12.01.2021 | ||
LU | 12.01.2021 | ||
BE | 31.01.2021 | ||
CH | 31.01.2021 | ||
LI | 31.01.2021 | ||
Former [2022/33] | AL | 22.07.2020 | |
AT | 22.07.2020 | ||
CZ | 22.07.2020 | ||
DK | 22.07.2020 | ||
EE | 22.07.2020 | ||
ES | 22.07.2020 | ||
FI | 22.07.2020 | ||
HR | 22.07.2020 | ||
IT | 22.07.2020 | ||
LT | 22.07.2020 | ||
LV | 22.07.2020 | ||
MC | 22.07.2020 | ||
NL | 22.07.2020 | ||
PL | 22.07.2020 | ||
RO | 22.07.2020 | ||
RS | 22.07.2020 | ||
SE | 22.07.2020 | ||
SI | 22.07.2020 | ||
SK | 22.07.2020 | ||
SM | 22.07.2020 | ||
BG | 22.10.2020 | ||
NO | 22.10.2020 | ||
GR | 23.10.2020 | ||
IS | 22.11.2020 | ||
PT | 23.11.2020 | ||
IE | 12.01.2021 | ||
LU | 12.01.2021 | ||
BE | 31.01.2021 | ||
CH | 31.01.2021 | ||
LI | 31.01.2021 | ||
Former [2022/07] | AL | 22.07.2020 | |
AT | 22.07.2020 | ||
CZ | 22.07.2020 | ||
DK | 22.07.2020 | ||
EE | 22.07.2020 | ||
ES | 22.07.2020 | ||
FI | 22.07.2020 | ||
HR | 22.07.2020 | ||
IT | 22.07.2020 | ||
LT | 22.07.2020 | ||
LV | 22.07.2020 | ||
MC | 22.07.2020 | ||
NL | 22.07.2020 | ||
PL | 22.07.2020 | ||
RO | 22.07.2020 | ||
RS | 22.07.2020 | ||
SE | 22.07.2020 | ||
SI | 22.07.2020 | ||
SK | 22.07.2020 | ||
SM | 22.07.2020 | ||
BG | 22.10.2020 | ||
NO | 22.10.2020 | ||
GR | 23.10.2020 | ||
IS | 22.11.2020 | ||
PT | 23.11.2020 | ||
IE | 12.01.2021 | ||
LU | 12.01.2021 | ||
CH | 31.01.2021 | ||
LI | 31.01.2021 | ||
Former [2021/52] | AL | 22.07.2020 | |
AT | 22.07.2020 | ||
CZ | 22.07.2020 | ||
DK | 22.07.2020 | ||
EE | 22.07.2020 | ||
ES | 22.07.2020 | ||
FI | 22.07.2020 | ||
HR | 22.07.2020 | ||
IT | 22.07.2020 | ||
LT | 22.07.2020 | ||
LV | 22.07.2020 | ||
MC | 22.07.2020 | ||
NL | 22.07.2020 | ||
PL | 22.07.2020 | ||
RO | 22.07.2020 | ||
RS | 22.07.2020 | ||
SE | 22.07.2020 | ||
SI | 22.07.2020 | ||
SK | 22.07.2020 | ||
SM | 22.07.2020 | ||
BG | 22.10.2020 | ||
NO | 22.10.2020 | ||
GR | 23.10.2020 | ||
IS | 22.11.2020 | ||
PT | 23.11.2020 | ||
LU | 12.01.2021 | ||
CH | 31.01.2021 | ||
LI | 31.01.2021 | ||
Former [2021/43] | AL | 22.07.2020 | |
AT | 22.07.2020 | ||
CZ | 22.07.2020 | ||
DK | 22.07.2020 | ||
EE | 22.07.2020 | ||
ES | 22.07.2020 | ||
FI | 22.07.2020 | ||
HR | 22.07.2020 | ||
IT | 22.07.2020 | ||
LT | 22.07.2020 | ||
LV | 22.07.2020 | ||
MC | 22.07.2020 | ||
NL | 22.07.2020 | ||
PL | 22.07.2020 | ||
RO | 22.07.2020 | ||
RS | 22.07.2020 | ||
SE | 22.07.2020 | ||
SI | 22.07.2020 | ||
SK | 22.07.2020 | ||
SM | 22.07.2020 | ||
BG | 22.10.2020 | ||
NO | 22.10.2020 | ||
GR | 23.10.2020 | ||
IS | 22.11.2020 | ||
PT | 23.11.2020 | ||
LU | 12.01.2021 | ||
Former [2021/40] | AL | 22.07.2020 | |
AT | 22.07.2020 | ||
CZ | 22.07.2020 | ||
DK | 22.07.2020 | ||
EE | 22.07.2020 | ||
ES | 22.07.2020 | ||
FI | 22.07.2020 | ||
HR | 22.07.2020 | ||
IT | 22.07.2020 | ||
LT | 22.07.2020 | ||
LV | 22.07.2020 | ||
MC | 22.07.2020 | ||
NL | 22.07.2020 | ||
PL | 22.07.2020 | ||
RO | 22.07.2020 | ||
RS | 22.07.2020 | ||
SE | 22.07.2020 | ||
SI | 22.07.2020 | ||
SK | 22.07.2020 | ||
SM | 22.07.2020 | ||
BG | 22.10.2020 | ||
NO | 22.10.2020 | ||
GR | 23.10.2020 | ||
IS | 22.11.2020 | ||
PT | 23.11.2020 | ||
Former [2021/36] | AL | 22.07.2020 | |
AT | 22.07.2020 | ||
CZ | 22.07.2020 | ||
DK | 22.07.2020 | ||
EE | 22.07.2020 | ||
ES | 22.07.2020 | ||
FI | 22.07.2020 | ||
HR | 22.07.2020 | ||
IT | 22.07.2020 | ||
LT | 22.07.2020 | ||
LV | 22.07.2020 | ||
NL | 22.07.2020 | ||
PL | 22.07.2020 | ||
RO | 22.07.2020 | ||
RS | 22.07.2020 | ||
SE | 22.07.2020 | ||
SI | 22.07.2020 | ||
SK | 22.07.2020 | ||
SM | 22.07.2020 | ||
BG | 22.10.2020 | ||
NO | 22.10.2020 | ||
GR | 23.10.2020 | ||
IS | 22.11.2020 | ||
PT | 23.11.2020 | ||
Former [2021/28] | AL | 22.07.2020 | |
AT | 22.07.2020 | ||
CZ | 22.07.2020 | ||
DK | 22.07.2020 | ||
EE | 22.07.2020 | ||
ES | 22.07.2020 | ||
FI | 22.07.2020 | ||
HR | 22.07.2020 | ||
IT | 22.07.2020 | ||
LT | 22.07.2020 | ||
LV | 22.07.2020 | ||
NL | 22.07.2020 | ||
PL | 22.07.2020 | ||
RO | 22.07.2020 | ||
RS | 22.07.2020 | ||
SE | 22.07.2020 | ||
SK | 22.07.2020 | ||
SM | 22.07.2020 | ||
BG | 22.10.2020 | ||
NO | 22.10.2020 | ||
GR | 23.10.2020 | ||
IS | 22.11.2020 | ||
PT | 23.11.2020 | ||
Former [2021/25] | AL | 22.07.2020 | |
AT | 22.07.2020 | ||
CZ | 22.07.2020 | ||
DK | 22.07.2020 | ||
EE | 22.07.2020 | ||
ES | 22.07.2020 | ||
FI | 22.07.2020 | ||
HR | 22.07.2020 | ||
IT | 22.07.2020 | ||
LT | 22.07.2020 | ||
LV | 22.07.2020 | ||
NL | 22.07.2020 | ||
PL | 22.07.2020 | ||
RO | 22.07.2020 | ||
RS | 22.07.2020 | ||
SE | 22.07.2020 | ||
SM | 22.07.2020 | ||
BG | 22.10.2020 | ||
NO | 22.10.2020 | ||
GR | 23.10.2020 | ||
IS | 22.11.2020 | ||
PT | 23.11.2020 | ||
Former [2021/22] | AT | 22.07.2020 | |
CZ | 22.07.2020 | ||
DK | 22.07.2020 | ||
EE | 22.07.2020 | ||
ES | 22.07.2020 | ||
FI | 22.07.2020 | ||
HR | 22.07.2020 | ||
IT | 22.07.2020 | ||
LT | 22.07.2020 | ||
LV | 22.07.2020 | ||
NL | 22.07.2020 | ||
PL | 22.07.2020 | ||
RO | 22.07.2020 | ||
RS | 22.07.2020 | ||
SE | 22.07.2020 | ||
SM | 22.07.2020 | ||
BG | 22.10.2020 | ||
NO | 22.10.2020 | ||
GR | 23.10.2020 | ||
IS | 22.11.2020 | ||
PT | 23.11.2020 | ||
Former [2021/20] | AT | 22.07.2020 | |
DK | 22.07.2020 | ||
ES | 22.07.2020 | ||
FI | 22.07.2020 | ||
HR | 22.07.2020 | ||
IT | 22.07.2020 | ||
LT | 22.07.2020 | ||
LV | 22.07.2020 | ||
NL | 22.07.2020 | ||
PL | 22.07.2020 | ||
RS | 22.07.2020 | ||
SE | 22.07.2020 | ||
BG | 22.10.2020 | ||
NO | 22.10.2020 | ||
GR | 23.10.2020 | ||
IS | 22.11.2020 | ||
PT | 23.11.2020 | ||
Former [2021/17] | AT | 22.07.2020 | |
ES | 22.07.2020 | ||
FI | 22.07.2020 | ||
HR | 22.07.2020 | ||
LT | 22.07.2020 | ||
LV | 22.07.2020 | ||
NL | 22.07.2020 | ||
PL | 22.07.2020 | ||
RS | 22.07.2020 | ||
SE | 22.07.2020 | ||
BG | 22.10.2020 | ||
NO | 22.10.2020 | ||
GR | 23.10.2020 | ||
IS | 22.11.2020 | ||
PT | 23.11.2020 | ||
Former [2021/10] | AT | 22.07.2020 | |
ES | 22.07.2020 | ||
FI | 22.07.2020 | ||
HR | 22.07.2020 | ||
LT | 22.07.2020 | ||
LV | 22.07.2020 | ||
PL | 22.07.2020 | ||
RS | 22.07.2020 | ||
SE | 22.07.2020 | ||
BG | 22.10.2020 | ||
NO | 22.10.2020 | ||
GR | 23.10.2020 | ||
IS | 22.11.2020 | ||
PT | 23.11.2020 | ||
Former [2021/09] | AT | 22.07.2020 | |
ES | 22.07.2020 | ||
FI | 22.07.2020 | ||
LT | 22.07.2020 | ||
SE | 22.07.2020 | ||
BG | 22.10.2020 | ||
NO | 22.10.2020 | ||
GR | 23.10.2020 | ||
PT | 23.11.2020 | ||
Former [2021/08] | ES | 22.07.2020 | |
FI | 22.07.2020 | ||
LT | 22.07.2020 | ||
SE | 22.07.2020 | ||
BG | 22.10.2020 | ||
NO | 22.10.2020 | ||
PT | 23.11.2020 | ||
Former [2021/07] | FI | 22.07.2020 | |
LT | 22.07.2020 | ||
NO | 22.10.2020 | Documents cited: | Search | [Y]WO9749688 (PFIZER [US], et al) [Y] 1-9 * page 10, line 1 - line 5; claim 1 *; | [Y]WO03082830 (BETA PHARMA INC [US]) [Y] 1-9* claims 1, 20 * | International search | [A]WO02088129 (WYETH CORP [US]) [A] 1-5, 7-9 * , the whole document, particularly embodiment *; | [A]CN1534026 (BEDA MEDICINE CO [US]) [A] 1-5, 7-9 * , the whole document, particularly embodiment *; | [A]CN101003515 (ASTRAZENECA AB [SE]) [A] 1-5, 7-9 * , the whole document, particularly embodiment *; | [A]CN102875570 (UNIV ZHEJIANG) [A] 1-4, 6-9 * , the whole document *; | [A]CN103965211 (JIANGSU AOSAIKANG PHARM CO LTD) [A] 1-4, 6-9* the whole document *; | [PX]CN104530063 (BEIJING DALITAI PHARMACEUTICAL TECHNOLOGY CO LTD) [PX] 1-9 * , the whole document * |